Stocks
JNJ Trades 37.7% Above Intrinsic Value Despite Attractive Dividend Profile
Johnson & Johnson (JNJ) is trading 37.7% above its intrinsic value, according to GuruFocus' GF Value model.
The company's dividend profile remains attractive and sustainable, with a yield of 1.95%, a payout ratio of 50%, and a three-year dividend growth rate of 4.9%.
JNJ's recent update from the COPERNICUS trial shows promising safety outcomes for its Rybrevant Faspro plus Lazcluze regimen in treating advanced non-small cell lung cancer patients.